Gardiner Nathaniel S. 4
4 · ENANTA PHARMACEUTICALS INC · Filed Feb 27, 2024
Insider Transaction Report
Form 4
Gardiner Nathaniel S.
Sr. VP & General Counsel
Transactions
- Exercise/Conversion
Common Stock
2024-02-26$8.99/sh+5,187$46,631→ 75,688 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-26−5,187→ 77,813 totalExercise: $8.99Exp: 2033-11-22→ Common Stock (5,187 underlying)
Holdings
- 35,926(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]These shares are held by grantor retained annuity trusts created by the reporting person for the benefit of himself and his two adult children.
- [F2]Such option became or will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 22, 2023).